Top Employer 2024 certification reflects Boehringer Ingelheim’s impactful people development in Asia Pacific
Boehringer Ingelheim is recognized as one of 17 Top Employers worldwide and for the fifth consecutive year in Asia Pacific High scores in development and steering (strategy and leadership) practices highlight Boehringer Ingelheim's continued commitment to employee wellbeing and development SINGAPORE, Jan. 18, 2024 /PRNewswire/ -- Boehringer Ingelheim has been awarded "Global Top Employer" for the fourth...
Top Employer 2024 certification reflects Boehringer Ingelheim’s impactful people development in Malaysia
Boehringer Ingelheim recognized as one of 17 Top Employers worldwide and for the sixth consecutive year in Malaysia High scores in development and steering (strategy and leadership) practices highlight Boehringer Ingelheim's continued commitment to employee wellbeing and development KUALA LUMPUR, Malaysia, Jan. 18, 2024 /PRNewswire/ -- Boehringer Ingelheim has been awarded "Global Top Employer" for the fourth year...
Top Employer 2024 certification reflects Boehringer Ingelheim’s impactful people development in Indonesia
Boehringer Ingelheim recognized as one of 17 Top Employers worldwide and for the sixth consecutive year in Indonesia High scores in development and steering (strategy and leadership) practices highlight Boehringer Ingelheim's continued commitment to employee wellbeing and development JAKARTA, Indonesia, Jan. 18, 2024 /PRNewswire/ -- Boehringer Ingelheim has been awarded "Global Top Employer" for the fourth year in...
Asian Smart Medical Online Exhibition 2024 Grand Opening
TAIPEI, Jan. 18, 2024 /PRNewswire/ -- Asian Smart Medical Online Exhibition (Medical Asia 2024) is a virtual and physical integration targeting Asian suppliers, importers, and exporters. It will be exhibited from January 17, 2024, to June 30, 2024, and will be an excellent opportunity for exhibitors to expose their brands. This transnational trade event, jointly organized by AsianNet and TradeAsia...
FDA CLEARANCE OF AMPLIA’S IND FOR PANCREATIC CANCER TRIAL IN US
HIGHLIGHTS The US FDA has cleared Amplia's Investigational New Drug (IND) Application for a clinical trial of narmafotinib in the USA The proposed trial would explore the combination of narmafotinib and FOLFIRINOX in advanced pancreatic cancer patients in the USA MELBOURNE, Australia, Jan. 18, 2024 /PRNewswire/ -- Amplia Therapeutics Limited (ASX: ATX), ("Amplia" or the "Company"), is pleased to...
EGYM and Life Fitness Expands Existing Global Partnership
MUNICH and ROSEMONT, Ill., Jan. 18, 2024 /PRNewswire/ -- EGYM, the global fitness technology and corporate health innovation leader, and Life Fitness, the global leader in commercial fitness equipment, are thrilled to announce the expansion of their strategic partnership, further elevating the cardio workout experience. This collaboration unites EGYM's cutting-edge fitness technology with Life Fitness' innovative cardio equipment, promising...
Seal Storage Technology Bolsters Compliance with HIPAA-Compliant Blockchain-Based Data Storage
TORONTO, Jan. 17, 2024 /PRNewswire/ -- - Seal Storage Technology, a leading provider of blockchain-powered cloud storage, is now able to enter Business Associate Agreements (BAAs) to handle protected health information (PHI) with its completion of HIPAA certification. Seal's compliance with HIPAA regulations is further enhanced by meeting the stringent standards set by the HITECH Act, solidifying Seal's role...
Seno Medical Earns Frost & Sullivan’s 2023 United States Enabling Technology Leadership Award for Delivering a More Efficient Breast Cancer Diagnosis with Its Cutting-edge Technology
Seno Medical offers highly differentiated opto-acoustic/ultrasound (OA/US) exam to diagnose breast cancer and significantly reduce unnecessary breast biopsies. SAN ANTONIO, Jan. 17, 2024 /PRNewswire/ -- Frost & Sullivan recently recognized Seno Medical with the 2023 US Enabling Technology Leadership Award. Seno Medical is a groundbreaking company founded in 2005 that revolutionized the breast cancer...
Lunit INSIGHT CXR Excels in Lung Nodule Detection – Exceptional Performance in Head-to-Head Study published in Radiology
- Lunit's AI-powered chest X-ray analysis solution shows highest AUC of 0.93 in a recent multi-center, multi-use case, multi-vendor lung nodule detection study SEOUL, South Korea, Jan. 17, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced an outstanding performance of its flagship product,...
Shaping International Economics and Ethical Dialogues Through the Leadership of Cheah Chyuan Yong
KUALA LUMPUR, Malaysia, Jan. 17, 2024 /PRNewswire/ -- Under the visionary leadership of Cheah Chyuan Yong, the International Strategy Institute (ISI) proudly declares the successful conclusion of two groundbreaking global conferences: the 12th World Chinese Economic Forum (WCEF) and the World Anti-Corruption Conference 2023 (WACC). These events, held in China and Indonesia respectively,...
